Maurice Petrasch

Successful methionine treatment for diffuse lung disease in a child with pathogenic MARS-1 gene variants

Aylin Pörtecene, Julia Carlens, Anibh M. Das, Maurice Petrasch et autres

Introduction Variants in the MARS- 1 gene lead to heterogeneous multisystem disorders involving the lungs, liver, hematopoietic system, immune system, and central nervous system (La Fay C et al., Eur J Med Genet 2021; 64(11): 104334). MARS-1 -associated pulmonary disorders have so …

de (code pays fourni par la source)

Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020–2022

Maren Doenhardt, Markus Hufnagel, Natalie Diffloth, Johannes Hübner et autres

By means of a nationwide, prospective, multicenter, observational cohort registry collecting data on 7375 patients with laboratory-confirmed SARS-CoV-2 admitted to children's hospitals in Germany, March 2020-November 2022, our study assessed the clinical features of children and adolescents hospitalized due to SARS-CoV-2, evaluated …

de, at (code pays fourni par la source)

Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients

Peter Lang, Thomas Eichholz, Tamam Bakchoul, Monika Streiter et autres

The pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 infection is a severe complication of coronavirus disease 2019. Since impaired coagulation and thrombosis/endotheliitis are suspected pathomechanisms, we treated 2 patients with defibrotide, a profibrinolytic, antithrombotic, antiinflammatory oligonucleotide. …

de (code pays fourni par la source)

Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol

Kai‐Dietrich Nüsken, Maurice Petrasch, Manfred Rauh, Wolfgang Stöhr et autres

BACKGROUND: Increased circulating visfatin may be associated both with endothelial damage and with increased mortality in end-stage renal disease (ESRD). HDL cholesterol is an independent, strong inverse predictor of cardiovascular events. However, associations between visfatin and parameters of lipid metabolism are unclear. …

de (code pays fourni par la source)

Preanalytical influences on the measurement of visfatin by enzyme immuno assay

Kai‐Dietrich Nüsken, Eva Nüsken, Maurice Petrasch, Manfred Rauh et autres

de (code pays fourni par la source)

Reduced plasma visfatin in end-stage renal disease is associated with reduced body fat mass and elevated serum insulin

KD Nüsken, Maurice Petrasch, Manfred Rauh, Wolfgang Stöhr et autres

Objectives: The adipocytokine visfatin has insulin-mimetic, anabolic properties and may be related to adiposity. End-stage renal disease (ESRD) is characterized by progressive catabolism. Glucose and insulin possibly regulate plasma visfatin concentrations. Therefore, we investigated circulating visfatin, insulin, glucose and body composition in …

de (code pays fourni par la source)